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Summary
Introduction:  There  is  an  ongoing  debate  about  the  optimal  use  of  metal-on-metal  (MoM)  bear-
ings in  total  hip  replacement,  since  there  are  uncertainties  about  local  and  systemic  adverse
effects due  to  wear  and  corrosion  of  these  bearings.  Despite  various  national  recommendations,
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efforts  to  achieve  international  harmonization  of  speciﬁc  evidence-based  recommendations  for
best practice  are  still  lacking.
Hypothesis:  An  international  consensus  study  group  should  be  able  to  develop  recommenda-
tions on  the  use  and  monitoring  of  MoM  bearings,  preferably  at  the  European  level,  through  a
multidisciplinary  approach,  by  integrating  the  perspectives  of  various  stakeholders.
Materials  and  methods:  Twenty-one  experts  representing  three  stakeholder  groups  and  eight
countries  participated  in  this  European  consensus  study,  which  consisted  of  a  consensus  meeting,
subsequent  structured  discussion,  and  consensus  voting.
Results:  The  current  statement  deﬁnes  ﬁrst  of  all  beneﬁts,  local  and  systemic  risks,  as  well
as uncertain  issues  related  to  MoM  bearings.  Safety  assessment  after  implantation  of  MoM
comprises  all  patients.  A  closer  follow-up  is  recommended  for  large  head  MoM  (≥  36  mm)  and
resurfacing.  In  these  implants  basic  follow-up  should  consist  of  x-rays  and  metal  ion  measure-
ment of  cobalt  in  whole  blood,  performed  with  GF-AAS  or  ICP-MS.  Clinical  and/or  radiographic
abnormality  as  well  as  elevated  ion  levels  needs  additional  imaging  (ultrasound,  CT-scan  and/or
MARS-MRI).  Cobalt  values  less  than  2  g/L  are  probably  devoid  of  clinical  concern,  the  threshold
value for  clinical  concern  is  expected  to  be  within  the  range  of  2—7  g/L.
Discussion:  This  is  the  ﬁrst  multinational,  interdisciplinary,  and  multiprofessional  approach
for developing  a  recommendation  for  the  use  and  monitoring  of  MoM  bearings  in  total  hip
replacement.  The  current  recommendations  are  in  partial  agreement  with  previous  statements
regarding  the  extent  of  follow-up  and  imaging  techniques.  They  however  differ  from  previous
communications  regarding  measurement  of  metal  ions  and  especially  the  investigated  medium,
technique, and  eventual  threshold  levels.
Level  of  evidence:  Level  V,  expert  opinion/agreement  conference.
© 2013  Elsevier  Masson  SAS.  All  rights  reserved.
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quent  structured  discussion  and  consensus  voting.  Overall,ntroduction
s  total  hip  replacement  (THR)  has  been  proven  to  be
 highly  effective  treatment  of  hip  osteoarthritis  in  the
lderly,  indications  were  subsequently  extended  to  young
nd  middle-aged  adults  as  well.  Increasing  demands  in
hese  patient  groups  due  to  signiﬁcant  physical  activity
nd  higher  life  expectancy  resulted  in  the  development
f  bearing  materials  with  improved  wear  characteris-
ics.  These  ‘‘hard-on-hard’’-bearings  are  characterized  by
otential  combinations  of  highly  cross-linked  polyethyl-
ne,  ceramic,  or  metal  cup  inserts  with  ceramic  or  metal
eads.
Metal-on-metal  (MoM)  bearings  have  been  used  with  con-
entional  THR  for  several  decades  with  promising  results
rom  early  applications  [1—4].  Low  wear  potential  of
echanically  well  investigated  prostheses,  no  relevant  risk
f  material  fracture,  and  a  high  design  variability  seemed  to
ustify  the  application  of  MoM  bearings  even  in  hip  resurfac-
ng  (HR)  and  large  head  hip  replacement  (LH-THR)  [5—7].
evertheless,  wear  and  corrosion  of  these  implants  may
ead  to  a  release  of  metal  products  into  surrounding  tissue
nd  body  ﬂuids  as  well  as  internal  organs.  Metal  accu-
ulation  may  result  in  local  ‘‘adverse  reactions  to  metal
ebris’’  (ARMD)  [8],  and  potentially  induce  systemic  adverse
ffects  (i.e.  toxicity,  teratogenicity  and  carcinogenicity)
9—12].  Recent  reports  on  pseudotumor—formation  after
esurfacing  [13—15]  and  high  failure  rates  of  speciﬁc  HR-  and
H-THR-implants  [16—19]  have  initiated  a  very  controver-
ial  discussion  about  the  biological  effects  of  MoM  implants
20—22].
Since  these  safety  concerns  have  been  raised,  sev-
ral  health  authorities  and  scientiﬁc  societies  in  different
2
p
tountries  have  published  recommendations  for  the  use  and
onitoring  of  MoM  implants  [23—27].
However,  most  of  them  are  focusing  on  clinical  issues
nd  do  not  take  patient  perspectives  (i.e.  appropriate
ommunication)  or  future  research  needs  into  account.  Typ-
cally  orthopaedic  surgeons  have  been  involved  in  national
rthopaedic  society  communications  and  other  disciplines
i.e.  allergology,  toxicology,  biomonitoring)  did  not  con-
ribute  signiﬁcantly.  Finally,  national  recommendations  have
o  take  speciﬁc  regulations  of  their  healthcare  systems  into
ccount  and  can  therefore  not  be  transferred  to  a  general-
zed  level  without  adaptions.
We  performed  an  international  consensus  study  on  the
se  of  metal-on-metal  bearings  for  total  hip  replacement.
rimary  aims  of  our  initiative  were:
 to  develop  recommendations  preferably  on  the  European
level;
 through  a  multidisciplinary  approach;
 integrating  the  perspectives  of  various  stakeholders  (i.e.
patients,  clinicians,  material  science  experts,  epidemiol-
ogists,  and  regulatory  agency  representatives).
aterial and methods
aterial
he  study  consisted  of  a  consensus  meeting  and  subse-4  experts  were  invited  to  participate  in  the  study  as
anel  members.  Twenty-one  (88%)  experts  representing
hree  stakeholder  groups  (physicians,  patients  regulatory
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Table  1  Characteristics  of  expert  panel.
Invited  (number)  Participated  (number,  %)
Field  of  expertise
Orthopaedic  Surgery  13  10  (77%)
Biomechanics  2  2  (100%)
Biomonitoring  2  2  (100%)
Basic research/Pathology  2  2  (100%)
Epidemiology/Occupational  medicine  2  2  (100%)
Allergology  1  1  (100%)
Patients regulatory  representative 1  1  (100%)
Regulatory  agency  representative 1  1  (100%)
Country
Germany 12  12  (100%)
Great Britain  3  2  (67%)
Austria 1  1  (100%)
France 1  1  (100%)
Spain 1  1  (100%)
USA 2  2  (100%)
Italy 1  1  (100%)
Netherlands  2  1  (50%)
Belgium 1  0  (0%)
Gender
Female 2  2  (100%)
22  19  (86%)
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representative,  regulatory  agency  representative),  and
eight  countries  participated  in  the  initiative  (Table  1).
Endorsement  was  given  by  ‘‘European  Federation
of  National  Associations  of  Orthopaedics  and  Trau-
matology’’  (EFORT),  ‘‘European  Hip  Society’’  (EHS),
‘‘Arbeitsgemeinschaft  Endoprothetik’’  (AE),  and  ‘‘German
Osteoarthritis  Society’’.  On  behalf  of  these  institutions,
the  organizers  (KPG,  JS)  proposed  potential  panel  members
based  on  their  expertise  and  previous  scientiﬁc  work  related
to  the  topic.
Methods
The  consensus  meeting  took  place  on  April  15—16,  2012  in
Dresden,  Germany.
Aim  of  the  expert  conference  was  to  develop  an
evidence-  and  consensus-based  recommendation  through  a
structured,  iterative  process  (Fig.  1).
Prior  to  the  meeting  the  following  ﬁve  key  questions  were
distributed  to  the  panel  members:
•  what  is  the  current  evidence  on  the  beneﬁts  (effective-
ness),  risks  and  uncertainties  of  metal-on-metal  (MoM)
bearings?
•  how  is  safety  assessment  of  patients  after  implantation  of
MoM  bearings  ensued?
•  what  are  the  indications  for  revision  of  MoM  implants  for
safety  reason?
•  what  is  the  appropriate  communication/distribution  of
recommendations  to  stakeholders?
•  what  are  unmet  medical  needs  for  future  research?
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sigure  1  Process  of  consensus  decision-making  of  statements
nd recommendations.
Brief  opening  presentations  addressed  available  surgical
nterventions  for  hip  osteoarthritis  focusing  on  MoM  bear-
ngs  and  currently  available  national  recommendations  for
he  use  of  MoM  implants.  They  included  current  evidence
n  metal  ion  concentrations  in  body  ﬂuids  after  MoM  THR,
he  characterization  of  local  tissue  response  due  to  metal
ebris,  potential  systemic  reactions  resulting  from  elevated
etal  ion  levels,  as  well  as  the  clinical  relevance  of  local
nd  systemic  reactions  including  therapeutic  options.
Following  the  presentations  every  participant  was  asked
o  assess  the  importance  of  each  question  and  the  avail-
bility  of  information/recommendations  in  the  scientiﬁc
iterature  on  a  Likert-scale  ranging  from  1  (lowest  relevance
nd  availability)  to  9  (highest  relevance  and  availabil-
ty).  It  was  deﬁned  that  the  scale  range  1—3  corresponds
o  a  low  relevance/availability  of  recommendations,  the
cale  range  4—6  to  a  mid-level  relevance/availability  of
266  
Table  2  Composition  of  groups.
Group  1  Group  2
Orthopaedics  (Moderator)  Allergology/
Epidemiology
(Moderator)
Basic  research  Pathology
Biomonitoring  Biomonitoring
Epidemiology  Occupational
medicine
Biomechanics  Biomechanics
Orthopaedics  Orthopaedics
Orthopaedics  Orthopaedics
Orthopaedics  Orthopaedics
Orthopaedics  Orthopaedics
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tRegulatory  agency  representative
ecommendations,  and  a  scale  range  7—9  to  high  rele-
ance/availability  of  information.  Additionally,  participants
ere  asked  to  prioritize  up  to  three  most  relevant  ques-
ions  related  to  MoM  bearings.  Median  ratings  as  well  as  the
nterquartile  range  (25th—75th  percentile)  of  each  question
ere  reported  back  to  the  expert  panel.
The  consensus  procedure  consisted  of  a  double-staged
rocess.  Participants  were  ﬁrst  divided  in  two  interdisci-
linary  groups  (Table  2).  Homogeneity  was  achieved  with
egard  to  the  distribution  of  disciplines  and  competencies
ithin  both  groups.
Firstly,  both  groups  independently  drafted  statements
nd  recommendations  to  the  ﬁve  key  questions  aiming  for
igh  intra-group  agreement.  Secondly,  both  groups  pre-
ented  the  acquired  statements  and  recommendations  to
ach  other.  For  each  question,  the  statements  of  both  groups
ere  discussed,  merged,  and  critically  revised  resulting  in
raft  answers  for  consensus  voting  by  the  whole  panel.
•
•
igure  2  Results  of  Ranking  of  the  ﬁve  key  questions,  showing  
ion/recommendation  for  each  of  them.F.  Hannemann  et  al.
It  was  determined  a  priori,  that  at  least  70%  of  the  par-
icipants  (equal  to  13  participants)  had  to  agree  with  a
tatement/recommendation  to  reach  a  consensus  within  the
hole  group.
During  the  conference,  a  consensus  was  achieved  on
uestions  1,  2,  and  3.  Working  groups  for  drafting  rec-
mmendations  for  the  remaining  questions  4  and  5  were
stablished  (question  4:  JS,  AH,  KPG,  WL;  question  5  PC,
M,  MAW).  Subsequent  to  the  conference,  the  proposals  for
uestions  4  and  5  were  sent  to  all  participants  for  online
onsensus  voting.  Proposals  for  modiﬁcation  were  consid-
red,  revised  suggestions  were  forwarded  until  consensus
as  reached.
esults
elevance  of  each  question  and  availability  of
nformation/recommendation
n  general,  the  relevance  of  all  ﬁve  key  questions  of  interest
as  considered  as  high  by  the  panel.  Availability  of  informa-
ion  however,  was  considered  moderate  at  most  (Fig.  2).
Research  priorities  concerning  MoM  bearings  as  deﬁned
y  the  panel  were:
 incidence  and  clinical  relevance  of  local  and  systemic
reactions  due  to  metal  wear  and  corrosion,  especially
with  regard  to  long-term  exposure  to  elevated  metal  ion
concentrations  (n  =  6  panel  members);
 importance  of  taper  connection  in  the  context  of  wear
and  corrosion  (n  =  3);
 kind  and  extent  of  postoperative  monitoring  (n  =  3);
 suitable  laboratory  procedures  for  determining  metal  ions
(n  =  2);
 threshold  levels  for  concentrations  of  metal  ions  in  body
ﬂuids  (n  =  1);
high  relevance  and  mostly  moderate  availability  of  informa-
al  be
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•  handling  of  asymptomatic  patients  at  risk  (n  =  1);
•  indications  for  revision  (n  =  1).
Process  of  consensus  ﬁnding
The  outcomes  of  the  group  work,  concerning  the  drafts  of
the  two  groups  for  the  recommendation,  were  similar  for
questions  1  to  3.  Issues  that  were  particularly  relevant  to
clinical  practice  such  as  indications  for  revision  and  thresh-
old  ion  levels  had  to  be  discussed  extensively  to  reach
consensus.
Recommendations
In  the  following,  the  ﬁnal  recommendations  of  the  consensus
panel  are  presented.  The  results  of  the  voting  for  questions
1  to  5  are  provided  in  parentheses.
What  is  the  current  evidence  on  the  beneﬁts
(effectiveness),  risks  and  uncertainties  of
Metal-on-Metal  bearings
What  are  the  beneﬁts  (effectiveness)?  (20  agreed  —  1
abstained  —  0  disagreed).
•  MoM  is  currently  the  only  technique  for  surface  replace-
ment;
•  there  are  no  polyethylene  particles  in  pure  MoM  bearings
that  may  cause  osteolysis;
•  MoM  bearings  produce  less  volumetric  wear  compared  to
conventional  polyethylene;
•  there  is  a  reduced  risk  of  fracture  in  MoM  bearings  com-
pared  to  ceramics;
•  large  head  total  hip  replacement  (THR)  (36  mm  head
size  and  larger)  as  well  as  hip  resurfacing  have  a
reduced  risk  of  dislocation  compared  to  small  head
THR  (28—32  mm  head  size).  In  large  head  THR  range
of  motion  increases  with  the  head  size  (only  up  to
40  mm);
•  hip  resurfacing  allows  more  preservation  of  bone  stock
on  the  femoral  side  when  compared  to  conventional
THR.
What  are  the  known  risks?  (21  agreed  —  0  abstained  —  0
disagreed).  Local  risks:
•  due  to  small  wear  particle  size  the  joint  capsule  is  exposed
to  a  larger  amount  of  particles  compared  with  polyethyl-
ene;
•  small  heads:  little  additional  risk  of  adverse  reaction
to  metal  debris  (ARMD)  when  compared  to  conventional
bearings;
•  large  heads:  higher  risk  for  ARMD  compared  to  conven-
tional  bearings.  Elevated  risk  of  taper  wear  and  rim
loading;
•  resurfacing:  risk  for  ARMD  esp.  with  decreasing  size,
female  patients,  and  low  coverage  arc.  Risk  for  femoral
neck  fracture.  Potentially  more  bone  consumption
at  acetabular  side  in  primary  cases  and  in  revision
cases.
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Systemic  risks:
 distribution  of  metal  products  to  nervous  system  and
other  organs  through  blood  circulation;
 accumulation  of  metal  ions  in  patients  with  renal  dysfunc-
tion  with  unknown  consequences.
hat  are  the  uncertain  issues?  (21  agreed  —  0  abstained  —
 disagreed).
 Long-term  effects  of  metal  products  (i.e.  particles,  ions,
metallo-organic  compounds)  including  systemic  effects
(i.e.  carcinogenicity,  teratogenicity,  and  toxicity);
 predictive  value  of  metal  ion  blood  levels  for  local  and
systemic  adverse  effects.
afety  assessment  of  patients  after  implantation  of  MoM
earings
s  systematic  follow-up  recommended?  If  yes  —  for  which
mplants  and  patients?  (20  agreed  —  1  abstained  —  0  dis-
greed).
 Yes,  for  all  patients  and  all  implants.  For  small  MoM  heads
in  THR  a systematic  follow-up  comparable  to  conventional
THR  is  sufﬁcient.  For  large  MoM  heads  and  resurfacing
closer  follow-up  is  recommended;
ow  long  and  how  frequently  should  asymptomatic  patients
e  monitored?  (17  agreed  —  3  abstained  —  0  disagreed;  one
xpert  left  the  meeting  before  voting).  For  the  life  of  the
oint:
 small  heads:  as  frequent  as  conventional  THR;
 large  heads:  annually;
 resurfacing:  annually  for  the  ﬁrst  5  years,  then  accord-
ing  to  local  protocols  for  patients  with  conventional  THR.
If  metal  ion  levels  are  normal  at  year  1  and  2  post-
operatively,  the  frequency  of  further  annual  follow-up
investigations  may  be  changed  to  local  protocols  for  con-
ventional  THR.  In  patients  with  risk  factors  such  as  small
size  (<  50  mm  femoral  component),  female  gender,  and
low  coverage  arc  annually  for  the  life  of  the  joint.
hich  imaging  techniques  should  be  applied  during  follow-
p?  (20  agreed  —  0  abstained  —  0  disagreed).
 X-rays  in  all  patients;
 in  case  of  clinical/radiographic  abnormality  additional
imaging  (ultrasound,  CT-scan,  and/or  MARS-MRI  [ordinary
MRI  without  MARS-technique  is  ineffective]);
 in  case  of  Co-values  above  a  certain  threshold  (within  the
range  of  2  to  7  g/L;  exact  level  still  to  be  determined):
ultrasound,  CT-scan,  and/or  MARS-MRI.
ow  should  monitoring  of  metal  ions  be  performed:
requency,  sources,  (blood/serum),  technique,  reference
alues?  (17  agreed  —  3  abstained  —  0  disagreed). Frequency:  time  of  regular  follow-up  in  asymptomatic
patients;  in  all  symptomatic  patients  additionally
between  regular  follow-up;
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 source:  metal  ion  determination  of  body  ﬂuids  can  be
performed  in  blood,  serum  and  urine.  At  present  mea-
surement  of  whole  blood  is  most  practical.  Co  should  be
monitored  as  reference  substance;
 technique:  metal  ion  measurement  must  be  performed
under  the  rules  of  internal/external  quality  control.  GF-
AAS  and  ICP-MS  are  considered  as  valid.  The  preferred
reporting  units  should  be  micrograms/liter  (=  ppb);
 reference  values:  Co-values  without  clinical  concern  are
at  the  moment:  less  than  2  g/L.  The  threshold  value  for
clinical  concern  is  expected  to  be  within  the  range  of  2
to  7  g/L  (exact  levels  have  still  to  be  determined  within
this  range);
 in  increased  values  above  the  threshold  additional  imag-
ing  even  in  asymptomatic  patients  is  recommended.
Note:  recommendations  are  based  on  local  effects;  criti-
al  values  for  systemic  effects  have  not  yet  been  established
or  patients  after  MoM  implantation.
hat  are  the  indications  for  revision  of  MoM  implants  for
afety  reasons?
hat  is  the  appropriate  management  for  local  ARMD?  (20
greed  —  0  abstained  —  0  disagreed).
 In  asymptomatic  patients  small  ﬂuid  collections  indica-
tive  of  ARMD  need  close  monitoring  (repeated  imaging  is
recommended);
 in  symptomatic  patients  and/or  patients  with  progressive
osteolysis,  large  or  expanding  pseudotumor,  and/or  pro-
gressive  neck  thinning,  and/or  Co-ions  above  threshold
level,  revision  should  be  considered.
hat  is  the  appropriate  management  for  elevated  metal
ons  in  asymptomatic  patients?  (What  is  a  critical  level/cut-
ff  level  for  clinically  relevant  complications?)  (19  agreed
 1  abstained  —  0  disagreed).
 In  asymptomatic  patients  elevated  levels  at  ﬁrst  detection
should  be  conﬁrmed  through  repeated  measurement;
 above  a  threshold  of  2  to  7  g/L  (exact  level  still  to
be  determined)  additional  imaging  and  closer  follow-
up  is  recommended.  In  case  of  pathological  results  of
additional  imaging  and/or  further  signiﬁcant  increase
of  Co-level,  revision  surgery  should  be  discussed  with
the  patient,  as  signiﬁcant  metal  accumulation  with  local
ARMD  is  to  be  expected  (especially  in  Co-values  >
20  g/L);
 in  case  of  excessive  elevation  (Co  approximately  20  g/L
or  above),  because  of  potential  osteolysis,  tissue  necrosis,
and  long-term  health  effects,  revision  surgery  should  be
discussed  with  the  patient;
 the  individual  risk-beneﬁt-ratio  should  be  considered
before  intervention.
s  routine  monitoring  of  metal  ions  necessary  after  removal?
20  agreed  —  0  abstained  —  0  disagreed).
 Routine  monitoring  of  metal  ions  after  removal  of
MoM  bearings  is  not  recommended,  as  no  effective
•F.  Hannemann  et  al.
interventions  can  currently  be  recommended  in  case  of
increased  metal  ions.
ppropriate  communication/distribution  of
ecommendations  to  stakeholders
hat  is  the  best  approach  to  communicate  with  patients?
21  agreed  —  0  abstained  —  0  disagreed).
 Before  intended  surgery  with  MoM  bearing  implants  every
patient  must  be  informed  comprehensively  in  written  and
oral  form  about  the  beneﬁts,  risks,  uncertainties,  and  rec-
ommended  monitoring  concerning  MoM  bearings.  There
should  be  a  dialogue  between  the  patient  and  the  sur-
geon;
 patients  with  already  implanted  large  head  MoM  THR
and  hip  resurfacing  should  be  informed  that  a  higher
frequency  of  monitoring  is  recommended  compared  to
conventional  MoM  bearings;
 risks  and  beneﬁts  should  be  expressed  by  patient-relevant
outcomes  such  as  morbidity,  health-related  quality  of  life,
and  risk  of  adverse  events.  Absolute  risk  estimations  are
preferable  to  relative  risk  estimations.  It  should  be  high-
lighted  that  a  complete  (100%)  prediction  of  positive  or
adverse  outcomes  is  not  possible.  Uncertainties  concern-
ing  both,  risks  and  beneﬁts,  should  be  made  explicitly;
 ideally,  the  patient  information  should  be  based  on  a  sys-
tematic  and  comprehensive  literature  review;
 the  information  should  allow  patients  informed  decision-
making  concerning  the  implantation  of  MoM  bearings  as
well  as  indication  for  revision  in  problem-cases;
 different  stakeholders  including  but  not  necessarily
limited  to  patient  organizations,  orthopedic  surgeons,
toxicologists,  and  epidemiologists  should  be  involved
in  the  development  of  the  patient  information.  Any
potential  conﬂicts  of  interest  of  persons  involved  in
the  development  of  the  patient  information  should  be
declared;
 the  access  to  the  information  should  be  possible  for  free
without  any  cost  barrier.  Information  may  be  disseminated
in  different  formats,  through  different  media,  and/or
organizations,  but  should  be  identical  in  content.
ow  should  surgeons  be  informed?  (21  agreed  —  0  abstained
 0  disagreed).  Information  provided  to  surgeons  should:
 cover  comprehensively  and  understandably  the  beneﬁts,
risks,  uncertainties,  and  recommended  monitoring  con-
cerning  MoM  bearings  including  product-related  as  well
as  implantation-related  aspects;
 include  the  advice  to  assess  and  consider  the  patient’s
individual  beneﬁt-to-risk-ratio  prior  to  surgery;
 include  the  recommendations  as  described  above  con-
cerning  safety  assessment  of  patients  after  implantation
of  MoM  bearings  as  well  as  indication  for  revision  surgery;
 be  based  on  a  systematic  and  comprehensive  literature
review.  The  information  should  highlight  the  evidence-
level  of  any  recommendation  (i.e.  expert  opinion,  single
RCT,  single  non-RCT,  meta-analysis  of  randomized/non-
randomized  studies);
 include  a  declaration  of  potential  conﬂicts  of  interest  of
persons  involved  in  the  development  of  the  information;
al  be
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•  be  disseminated  in  different  formats,  through  different
media,  and/or  organizations,  but  should  be  identical  in
content;
•  be  provided  to  other  medical  disciplines  (i.e.  neurologists,
cardiologists,  oncologists)  as  patients  with  MoM  implants
may  seek  their  advice.
Unmet  medical  needs  for  future  research?
Preclinical  research:  (21  agreed  —  0  abstained  —  0  dis-
agreed).  It  is  necessary,  to:
•  investigate  the  inﬂuence  of  relevant  parameters  on  wear
and  corrosion  of  taper  connections  (taper  size,  diame-
ter  and  length),  material,  texture,  head  diameter,  joint
articulation  friction,  assembly  forces  and  direction.  Wear
products  from  taper  interfaces  and  joint  articulation
should  be  differentiated,  if  possible;
•  determine  the  mechanisms  creating  particles/ions/
metallo-organic  compounds  or  aggregates  in  large
(≥  36  mm)  and  small  (<  36  mm)  MoM  bearings  functioning
under  ideal  and  suboptimal  conditions.  The  distribution
of  nanoparticles  should  be  determined;
•  determine  the  potential  impact  of  additional  metal  ions
(i.e.  titanium);
• investigate  the  interaction  between  wear  and  corrosion
of  MoM  interfaces  and  to  develop  appropriate  preclinical
testing  methods;  means  (by  design  or  metallurgy)  to  avoid
synergistic  corrosion  effects  should  be  identiﬁed;
•  establish  in  vitro  models  to  investigate  local  and  systemic
consequences  of  metal  debris  (i.e.  3-d  scaffolds).
Clinical  research  (21  agreed  —  0  abstained  —  0  disagreed).
It  is  necessary,  to:
•  perform  comparative  tests  to  identify  reproducibility  of
metal  ion  measurements  among  different  labs;
•  investigate  urine  as  a  screening  tool  for  malfunctioning
MoM  bearings;
• determine  metal  ion  levels  after  the  implantation  of  any
kind  of  artiﬁcial  implant  (i.e.  knee  arthroplasty,  spine
implants  and  osteosythesis  devices)  and  to  investigate
associations  with  clinical  symptoms;
•  establish  joint  registries  with  better  documentation  of
revision  reasons;
•  examine  correlations  between  the  presence  of
wear/corrosion  at  taper  connections  and  the  pres-
ence/extent  of  adverse  local  tissue  reactions  (i.e.
necrosis,  pseudotumor);
•  determine  true  incidence  as  well  as  clinical  relevance
of  ARMD  in  all  MoM  implants.  Adverse  reactions  from
small/large  head  MoM  THR  should  be  compared  to  that
of  hip  resurfacing;
• determine  the  local  and  systemic  distribution  and
pathological  effects  of  particles/ions/metallo-organic
compounds  produced  in  MoM  bearings;•  investigate  effects  of  long-term  exposure  to  metal  ion
concentrations  between  2  and  7  g/L  by  determining  the
change  in  circulating  T-  and  B-cells  in  patients  with  vary-
ing  levels  of  metal  ions;
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 determine  the  incidence  and  clinical  relevance  of  poten-
tial  systemic  effects  of  metal  products  including  organ
toxicity,  carcinogenicity  and  teratogenicity.
iscussion
his  is  the  ﬁrst  multinational,  interdisciplinary  and  mul-
iprofessional  approach  to  develop  recommendations  for
he  use  of  MoM  bearings  for  total  hip  replacement.  Unlike
everal  previous  communications  [25—27]  our  consensus
tudy  and  the  resulting  recommendations  for  the  use  of  MoM
earings  are  based  on  the  opinion  of  experts  from  different
edical  ﬁelds  and  stakeholder  groups  including  patients,
linical  experts,  methodologists,  and  regulators.  Consensus
ethods  such  as  explicit  rules  and  an  iterative,  structured
rocess  involving  all  panel  members  have  been  employed  to
enerate  consensus.  Endorsement  of  the  consensus  initiative
as  given  by  ‘‘European  Federation  of  National  Associations
f  Orthopaedics  and  Traumatology’’  (EFORT),  ‘‘European
ip  Society’’  (EHS),  the  German  ‘‘Arbeitsgemeinschaft
ndoprothetik’’  (AE),  and  ‘‘German  Osteoarthritis
ociety’’.
In  addition  to  these  strengths,  our  study  also  has
ome  limitations.  Although  the  panel  was  well-staffed  with
nternational  and  multidisciplinary  participants,  German
articipants  and  orthopaedic  surgeons  were  overrepre-
ented,  however  German  participants  represented  eight
elds  of  expertise.  As  up  to  date  systematic  reviews  or
eta-analyses  concerning  the  risks,  beneﬁts  and  uncertain-
ies  of  MoM  bearings  are  missing,  panel  members  based
heir  votes  on  individual  knowledge  of  the  best  available
esearch  evidence  as  well  as  their  clinical  experience.  Cur-
ently,  a systematic  review  is  being  performed  by  members
f  our  panel.  Preliminary  results  seem  to  support  the  recom-
endations  of  the  presented  consensus  study  i.e.  threshold
evels  of  metal  ion  concentrations,  but  heterogeneity  in
tudy  designs,  patient  populations,  and  methodological
pproaches  does  not  allow  a  straight  forward  summary  of
he  published  evidence.  Therefore,  multiperspective  and
ultiprofessional  expert  knowledge  and  experience  is  highly
aluable  to  provide  appropriate  guidance  to  clinicians  and
onsumers.
Our  recommendation  is  in  partial  agreement  with  pre-
ious  statements  from  national  societies  and  institutions
23—28]. In  our  statement,  as  well  as  in  other  statements,
he  patient  management  depends  on  the  type  of  prosthe-
is,  as  the  clinical  relevance  of  metal-related  problems  in
mall  head  MoM  THR  is  clearly  smaller  than  the  relevance  of
arge  head  THR  (head  diameter  36  mm  or  larger)  and  resur-
acing  devices.  In  the  latter,  speciﬁc  design  types  (i.e.  ASR
esurfacing)  and  unfavorable  positioning  need  special  atten-
ion  [23,26,27].  In  most  recommendations  [23,25,26,28]  a
ystematic  follow-up  for  patients  with  large  head  THR  and
esurfacing  with  annual  clinical  follow-up  examinations  (at
east  for  5  years,  if  not  lifelong)  is  proposed.  The  need  for
ppropriate  imaging  is  also  an  issue  where  all  published
tatements  agree:  conventional  radiography  should  be  sup-
lemented  by  ultrasound,  CT-scans  and/or  MRI  in  order  to
etect  soft-tissue  destruction.  If  MRI  is  performed,  metal
rtifact  reduction  sequence  (MARS)  technique  is  recom-
ended.
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The  primary  focus  of  our  expert  consensus  recommen-
ation  is  the  safety  of  patients,  who  have  received  MoM
mplants  in  the  past  or  will  undergo  operations  in  the  future.
e  are  aware  that  the  recommended  routine  monitoring
easures  with  systematic  follow-up  investigations  includ-
ng  metal  ion  analysis  and  imaging  may  also  have  economic
mpact.  To  address  this  issue,  however,  was  not  the  focus  of
ur  consensus  study.  Future  health-economic  investigations
re  necessary  to  evaluate  the  long-term  cost-effectiveness
f  the  recommendations  made.  Such  investigations  should
ot  only  include  the  ﬁnancial  burden  which  is  created  by
iagnostic  algorithms  but  also  the  economic  impact  caused
y  surgical  treatment  at  early  versus  late  stages  of  local
nd  systemic  ARMD.  In  addition,  substantial  differences  of
ational  reimbursement  procedures  regarding  cost  regu-
ation  of  monitoring  programs  may  be  expected  amongst
ifferent  countries.
Recommendations  regarding  metal  ion  analysis  are  con-
roversial:  there  is  no  international  consensus  whether
hromium  and/or  cobalt  should  be  monitored.  Threshold
evels  for  further  investigations  are  only  provided  by  some
nstitutions  [26,27].  They  indicate  that  a  blood  metal  ion
evel  of  larger  than  7  ppb  indicates  potential  for  soft  tissue
eaction  [27].  Others  feel  that  there  is  not  enough  evidence
or  setting  clear  cut-off  levels  in  serum  or  blood  that  would
erve  as  a  trigger  for  intervention  or  correlate  with  adverse
ystemic  effects  for  individual  patients  [23,25,28]. While
everal  investigators  have  provided  median  concentrations
and  ranges)  of  cobalt/chromium  ion  levels  corresponding
ith  good  or  bad  functioning  MoM  implants  [8,13—15,18,29],
nly  Hart  et  al.  [30]  and  van  der  Straeten  et  al.  [31]
eport  precise  threshold  levels  (e.g.  in  the  latter  study,
.97  ppb  and  4.0  g/L  for  cobalt  in  unilaterally  operated
atients)  with  additional  information  regarding  sensitivity
63%  respectively  25%)  and  speciﬁcity  (86%  respectively  95%)
f  these  values.  Taking  into  account  these  observations,  the
reviously  deﬁned  institutional  recommendations  to  set  a
ut-off  level  of  7  g/L  are  not  anymore  sufﬁcient  and  should
e  changed  appropriately.
Currently  no  evidence  exists  that  cobalt  concentrations
elow  a  level  of  less  than  2  g/L  are  generally  associated
ith  metal-related  health  problems.  Therefore  we  devel-
ped  the  consensus  opinion  that  cobalt  should  be  used  as
he  reference  with  values  less  than  2  g/L  representing  a
evel  without  clinical  concern  (in  the  absence  of  clinical
igns  or  symptoms  of  local  adverse  reactions).  In  addition
e  have  deﬁned  a  range  of  2  to  7  g/L,  where  we  expect  a
uture  threshold  value  for  clinical  concern  when  appropri-
te  evidence  becomes  available  to  develop  a  precise  cut-off
evel.
Our  recommendation  of  a  threshold  level  within  the
ange  of  2  to  7  g/L  relates  to  unilateral  MoM  hip  implants
xclusively.  Currently  there  is  not  enough  data  available  to
ive  any  valid  statement  on  cut-off  levels  neither  for  bilat-
ral  MoM  hip  implants  nor  for  other  metal  implants  (i.e.  knee
rthroplasty  or  osteosynthesis  devices).
Hardly  any  published  statement  gives  a  recommenda-
ion  about  the  appropriate  source  of  metal  ion  analysis
i.e.  whole  blood,  serum,  urine)  measurement  technique
nd  information  if  chromium  and/or  cobalt  ion  levels  shall
e  measured  [23—28].  Metal  ion  determination  of  body  ﬂu-
ds  can  be  performed  in  blood,  serum  and  urine.  Our  panelF.  Hannemann  et  al.
embers  feel  that  at  present  measurement  of  cobalt  levels
n  whole  blood  is  most  practical.
We  are  aware  that  the  availability  of  qualiﬁed  laborato-
ies  with  the  ability  to  perform  routine  metal  ion  analyses
ay  be  limited.  It  may  also  be  difﬁcult  to  identify  appropri-
te  institutions  during  routine  THR  follow-up  investigations.
rom  our  point  of  view  it  is  necessary,  however,  to  develop
ndividual  arrangements  on  an  institutional  level  to  provide
ualiﬁed  and  valid  mechanisms  of  metal  ion  analyses  as  an
mportant  measure  of  risk  assessment.
In  addition  we  have  listed  detailed  proposals  for  commu-
ication  with  relevant  stakeholders.  We  consider  it  as  very
mportant  to  inform  patients  as  well  as  surgeons  about
he  current  medical  background  regarding  indication  for
urgery  with  MoM  implants  as  well  as  appropriate  monitoring
lternatives.
Finally,  we  made  speciﬁc  recommendations  regarding
 detailed  agenda  of  research  questions  which  should  be
ddressed  in  the  future.  Considering  the  lack  of  relevant
nformation  in  several  important  areas,  it  is  mandatory  to
btain  better  information  through  targeted  research.  An
mproved  MoM  patient  outcome  data  base  should  enable
s  to  extend  the  aforementioned  recommendations  in  the
uture  and  to  answer  relevant  questions  more  speciﬁcally.
he  recommended  research  should  be  supported  by  the  dif-
erent  stakeholder  groups.
In  summary,  we  have  developed  recommendations  for
oM  bearings  based  on  clinical  practice  and  the  best  cur-
ently  available  research  evidence.  The  current  consensus
tatement  contains  information  on  the  appropriate  follow-
p  for  patients  with  already  implanted  MoM  devices  as  well
s  detailed  recommendations  for  communication  with  stake-
olders  and  necessary  research  activity.  We  hope  that  this
nformation  contributes  to  the  management  of  patients  with
oM  THR  or  HR  and  helps  to  identify  future  research  needs.
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